Section 630.230 - Prohibited professional conduct1. A person who is licensed as a physician or physician assistant shall not: (a) Falsify records of health care;(b) Falsify the medical records of a hospital so as to indicate his or her presence at a time when he or she was not in attendance or falsify those records to indicate that procedures were performed by him or her which were in fact not performed by him or her;(c) Render professional services to a patient while the physician or physician assistant is under the influence of alcohol or any controlled substance or is in any impaired mental or physical condition;(d) Acquire any controlled substances from any pharmacy or other source by misrepresentation, fraud, deception or subterfuge;(e) Prescribe anabolic steroids for any person to increase muscle mass for competitive or athletic purposes;(f) Make an unreasonable additional charge for tests in a laboratory, radiological services or other services for testing which are ordered by the physician or physician assistant and performed outside his or her own office;(g) Allow any person to act as a medical assistant in the treatment of a patient of the physician or physician assistant, unless the medical assistant has sufficient training to provide the assistance;(h) Fail to provide adequate supervision of a medical assistant who is employed or supervised by the physician or physician assistant, including, without limitation, supervision provided in the manner described in NAC 630.810 or 630.820;(i) If the person is a physician, fail to provide adequate supervision of a physician assistant or anesthesiologist assistant or adequate collaboration with an advanced practice registered nurse with whom the physician is collaborating;(j) Fail to honor the advance directive of a patient without informing the patient or the surrogate or guardian of the patient, and without documenting in the patient's records the reasons for failing to honor the advance directive of the patient contained therein;(k) Engage in the practice of writing prescriptions for controlled substances to treat acute pain or chronic pain in a manner that deviates from the policies set forth in the Guidelines for the Chronic Use of Opioid Analgesics adopted by reference in NAC 630.187;(l) Administer or use, or allow any person under his or her supervision, direction or control to administer or use, a single-use medical device: (1) For more than one procedure;(2) For more than one patient; or(3) In a manner inconsistent with the manufacturer's instructions or directions included on or with the single-use medical device;(m) Require or ask a patient to waive his or her right to file a complaint with the Board; or(n) Condition care or treatment on the provision of a waiver described in paragraph (m).2. A physician or physician assistant shall comply with all applicable provisions of chapters 440 and 629 of NRS and any regulation adopted pursuant thereto.3. As used in this section: (a) "Chronic pain" has the meaning ascribed to it in section 3 of the Guidelines for the Chronic Use of Opioid Analgesics adopted by reference in NAC 630.187.(b) "Single-dose vial" means a vial, including, without limitation, a sealed sterile vial, which may be accessed by insertion of a needle and which, according to the manufacturer's instructions: (1) Contains only one dose of a medication; and(2) May be used for only one patient.(c) "Single-use medical device" means a medical device that is intended for one use or on a single patient during a single procedure and includes, without limitation, a blade, clip, catheter, implant, insufflator, lancet, needle, sleeve, syringe and single-dose vial.Nev. Admin. Code § 630.230
Bd. of Medical Exam'rs, § 630.230, eff. 12-20-79-NAC A 6-23-86; 9-19-90; 1-13-94; 7-18-96; R007-99, 9-27-99; R089-00, 7-19-2000; R108-01, 11-29-2001; R052-10, 10-15-2010; R059-11, 5-30-2012; R094-12, 2-20-2013; A by R001-14, eff. 6/26/2015; A by R057-14, eff. 6/26/2015; A by R008-17A, eff. 8/21/2019; A by R002-23A, eff. 11/9/2023; A by R069-23A, eff. 4/19/2024; A by R033-24A, eff. 8/13/2024; A by R068-23A, eff. 8/23/2024